NeoVirTech starts a collaboration with Transgene SA

NeoVirTech SAS, a biotechnology company developing autofluorescent viruses to decipher viral infection in vivo and to detect and measure antiviral activities started a collaboration with Transgene SA, a biopharmaceutical company focused on discovering and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Combination of NeoVirTech’s technology with Transgene products provides an unprecedented way to understand and control viral infection directly using microscopy imaging.


A new patent

In collaboration with Dr. Anne-Françoise Tilkin Mariamé (INSERM/Toulouse) and INSERM-Transfert, NeoVirTech deposit a patent protection of a repositioned molecule for the treatment of metastatic melanoma. This FDA approved molecule was discovered during a screening campaign managed by NeoVirTech.